Prescott, I A <br/><br/>
Levodopa enhances synaptic plasticity in the substantia nigra pars reticulata of Parkinson's disease patients.  [electronic resource] 

 -  Brain : a journal of neurology  Feb 2009 
 - 309-18 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1460-2156 
<br/><br/><label>Standard No.: </label>10.1093/brain/awn322  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antiparkinson Agents--therapeutic use<br/>Basal Ganglia--physiopathology<br/>Deep Brain Stimulation<br/>Evoked Potentials--drug effects<br/>Female<br/>Humans<br/>Levodopa--therapeutic use<br/>Male<br/>Microelectrodes<br/>Middle Aged<br/>Neuronal Plasticity--drug effects<br/>Parkinson Disease--drug therapy<br/>Stimulation, Chemical<br/>Substantia Nigra--drug effects